PDF(2402 KB)
进口血竭质量新问题及控制方法研究
罗定强, 杜玮, 黄艳, 樊宝娟, 杨亚丽, 刘嘉澍, 魏锋, 马双成
中国药学杂志 ›› 2019, Vol. 54 ›› Issue (21) : 1794-1796.
PDF(2402 KB)
PDF(2402 KB)
进口血竭质量新问题及控制方法研究
New Quality Problems and Control Methods for Imported Draconis Sanguis
目的 探讨从产地印尼进口血竭药材出现的质量新问题。方法 对10批进口血竭与3批血竭果实,分别按进口药材质量标准检验及拟定的方法进行探索性分析。结果 3批进口血竭性状鉴定为不合格, 另1批样品因添加龙血竭判定为不合格。结论 3批血竭果实中血竭素的含量范围为1.2%～2.4%,3批进口血竭采用血竭果实直接粉碎加工;1批血竭按拟定的方法检出了龙血竭素A、B,即添加了龙血竭。
OBJECTIVE To explore the new quality problems of Draconis Sanguis imported from Indonesia. METHODS According to the quality standard of imported medicinal materials and Ch.P method, exploratory analysis was carried out on 10 batches of imported Draconis Sanguis and three batches of Draconis Sanguis fruits. RESULTS The dracohodin content in three batches of Draconis Sanguis fruits was 1.2%-2.4%. Three batches of imported Draconis Sanguis were obtained by directly pulverization of Draconis Sanguis fruits, and loureirin A and loureirin B were detected in one batch of Draconis Sanguis, suggesting that dracaena cochinchinensis was added. CONCLUSION Among the 10 batches of imported Draconis Sanguis, three batches are determined to be unqualified due to character inconformity, and the other batch is judged to be unqualified due to the addition of dracaena cochinchinensis.
血竭 / 果实 / 质量 / 龙血竭素A / 龙血竭素B {{custom_keyword}} /
Draconis Sanguis / fruits / quality / loureirin A / loureirin B {{custom_keyword}} /
[1] Ch.P (2015). VolⅠ(中国药典2015年版.一部)[S]. 2015:142-143.
[2] LIU A, LI A X,LI H. Clinical application of Draconis Sanguis[J]. Chin Pract Med(中国实用医药杂志), 2014, 9(1) : 262-263.
[3] YI T,CHEN H B,ZHAO Z Z, et al. Comparison of the chemical profiles and anti-platelet aggregation effects of two “Dragon′s Blood” drugs used in traditional Chinese medicine[J]. J Ethnopharm, 2011,133(2):796-802.
[4] LI M, LIU J, LV X N, et al. ATR-FTIR Technique in iidentification of adulteration in imported draconis[J]. World Chin Med(世界中医药), 2016, 10(11):2123-2129.
[5] ZHENG Z Q,SHI J L,JIANG Y N, et al. Rapid distinguish and authenticity identification of Draconis Resina and Draconis Sanguis by TG-DTA [J]. Inf Tradit Chin Med (中医药信息), 2018, 35(3):30-36.
[6] ZHENG Z Q,SHI J L,DING Y S, et al. Distribution and correlation analysis of trace elements in Draconis Resina and Draconis Sanguis [J]. Chin J Pharm Anal (药物分析杂志), 2019, 39(3):418-425.
[7] CFDA [ 2004 ] NO.144 ( 43种进口中药材质量标准)[S]. 2015:19-20.
[8] WU C H,FENG C,YANG L, et al. Determination of four essential oils in Cinnamomum cassia by quantitative analysis of multi-components by single marker[J]. Chin Pharm J ( 中国药学杂志),2019,54(5) : 400-406.
[9] ZHOU P P,ZHOU L,SUN Z, et al. Qualitative and quantitative analysis of danshen-chuanxiongqin injection by using UHPLC-Q-Orbitrap HRMS [J]. Chin Pharm J ( 中国药学杂志),2019,54(4):327-333.
[10] SHI S L,HOU Y R, GENG Y, et al. High performance liquid chromatography combined with pulsed amperometric detection for the analysis of Ribostamycin Sulfate [J]. Chin Pharm J (中国药学杂志),2019,54(4):321-326.
/
| 〈 |
|
〉 |
